Oncogenes and tumor suppressor genes

Last updated: November 01, 2022

Oncogenes and tumor suppressor genes

Watch later

Watch later

Amino acid metabolism
Nitrogen and urea cycle
Hartnup disease
Ornithine transcarbamylase deficiency
Maple syrup urine disease
Homocystinuria
Phenylketonuria (NORD)
Abetalipoproteinemia
Hypertriglyceridemia
Hyperlipidemia
Vitamin B12 deficiency
Nucleotide metabolism
Cholesterol metabolism
Disorders of amino acid metabolism: Pathology review
Purine and pyrimidine synthesis and metabolism disorders: Pathology review
Adenosine deaminase deficiency
Severe combined immunodeficiency
Gout
Diabetes mellitus: Pathology review
Physiological changes during exercise
Endocrine system anatomy and physiology
Glucagon
Insulin
Fats and lipids
Lipid-lowering medications: Fibrates
Lipid-lowering medications: Statins
Free radicals and cellular injury
Ischemia
Hypoxia
Atrophy, aplasia, and hypoplasia
Hyperplasia and hypertrophy
Metaplasia and dysplasia
Oncogenes and tumor suppressor genes
Anorexia nervosa
Bulimia nervosa
Eating disorders: Pathology review
Vitamin K deficiency
Vitamin D deficiency
Excess Vitamin A
Excess Vitamin D
Folate (Vitamin B9) deficiency
Niacin (Vitamin B3) deficiency
Vitamin C deficiency
Wernicke-Korsakoff syndrome
Beriberi
Iodine deficiency
Zinc deficiency
Marasmus
Kwashiorkor
Fat-soluble vitamin deficiency and toxicity: Pathology review
Zinc deficiency and protein-energy malnutrition: Pathology review
Water-soluble vitamin deficiency and toxicity: B1-B7: Pathology review
Familial adenomatous polyposis
Azoles
Echinocandins
Miscellaneous antifungal medications
Miscellaneous cell wall synthesis inhibitors
Cell wall synthesis inhibitors: Cephalosporins
Protein synthesis inhibitors: Aminoglycosides
Mycobacterium tuberculosis (Tuberculosis)
Tuberculosis: Pathology review
Anatomy of the leg
Dementia with Lewy bodies
Bones of the cranium
Anatomy of the cranial base
Anatomy of the orbit
Anatomy of the eye
Anatomy of the nose and paranasal sinuses
Anatomy of the oral cavity
Anatomy of the temporomandibular joint and muscles of mastication
Muscles of the face and scalp
Anatomy of the salivary glands
Nerves and vessels of the face and scalp
Anatomy of the tongue
Anatomy of the pterygopalatine (sphenopalatine) fossa
Anatomy of the inner ear
Anatomy of the infratemporal fossa
Anatomy of the external and middle ear
Anatomy clinical correlates: Skull, face and scalp
Anatomy clinical correlates: Ear
Anatomy clinical correlates: Eye
Anatomy clinical correlates: Temporal regions, oral cavity and nose
Gallbladder histology
Esophagus histology
Stomach histology
Small intestine histology
Colon histology
Liver histology
Pancreas histology
Laxatives and cathartics
Antidiarrheals
Acid reducing medications
Esophageal disorders: Pathology review
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Inflammatory bowel disease: Pathology review
Malabsorption syndromes: Pathology review
Diverticular disease: Pathology review
Appendicitis: Pathology review
Gastrointestinal bleeding: Pathology review
Colorectal polyps and cancer: Pathology review
Pancreatitis: Pathology review
Gallbladder disorders: Pathology review
Jaundice: Pathology review
Viral hepatitis: Pathology review
Cirrhosis: Pathology review
Hepatitis A and Hepatitis E virus
Hepatitis D virus
Hepatitis C virus
Adrenocorticotropic hormone
Growth hormone and somatostatin
Oxytocin and prolactin
Antidiuretic hormone
Thyroid hormones
Synthesis of adrenocortical hormones
Cortisol
Cyanotic congenital heart defects: Pathology review

Transcript

Watch video only

Oncogenes and tumor suppressor genes are classes of genes that code for various proteins that are involved in the progression of the cell cycle.

Oncogenes are actually mutated versions of proto-oncogenes, which are normal genes in charge of positive regulation of the cell-cycle.

So the protein products of proto-oncogenes stimulate cell growth and division - they’re like a gas pedal in a car.

Tumor suppressor genes, on the other hand, are in charge of negative regulation of the cell cycle, so their protein products stop its progression and promote apoptosis or cell death.

Tumor suppressor genes are involved in DNA repair mechanisms and inhibiting transcription factors that try to push the cell along in the cell cycle - so they’re like the brake pedal in a car.

Now, the cell cycle is the series of events that a cell goes through as it changes from being one cell into two daughter cells.

The cell cycle has two phases: interphase and mitosis. Interphase is comprised of the G1 phase, during which the cell grows and performs its cell functions, the S phase, during which DNA is replicated, and the G2 phase, during which the cell grows again before entering mitosis.

At the end of G1 and G2, there are cell cycle control points called the G1 and G2 checkpoints, where the cell checks to see if there’s any DNA damage.

The main control point is the G1 checkpoint.

If it turns out that there is DNA damage, then the cell can either enter a non-dividing state called the G0 phase, where the DNA repair mechanisms try to fix the problem, or the cell can self-destruct in a process called apoptosis.

Now, if the cell does get the go-ahead at the G1 checkpoint, it enters the S phase.

And then if the cell gets past the G2 checkpoint, it enters mitosis, and it divides in two identical daughter cells.

However, once cells differentiate and become mature cells - like liver cells for example - they don’t necessarily go through the cell cycle over and over again.

Actually, cells tend to stay in that G0 phase, and some cells, like neurons, stay in G0 their entire life.

Most other cells, however, stay in G0 until they get an external signal like a growth factor.

These growth factors can be secreted by other cells, or by the cell itself, like when there’s a tissue injury, and the remaining cells need to divide to replace the lost cells.

Growth factors bind to growth factor receptors in the cell’s membrane, which activates signal transduction proteins.

Ultimately that leads to increased transcription of genes that code for special proteins - like cyclins and cyclin dependent kinases - so more of these proteins are being made.

This is important because whether or not a cell gets cleared at G1 and G2, depends largely on the activity of cyclin dependent kinases, which add phosphate groups to various proteins within the cell.

And these cyclin dependent kinases are, as you might guess, dependent on cyclin proteins.

So what happens is that when there’s DNA damage, the cell doesn’t produce cyclins, the cyclin dependent kinases can’t phosphorylate proteins within the cell, and that’s the signal for the cell to halt the cell cycle.

Okay, so proto-oncogenes code for proteins involved in promoting the progression of the cell-cycle.

Examples of proto-oncogenes include genes that code for growth factors or growth factor receptors - like the receptor tyrosine kinase or RTK which adds phosphate groups to other proteins.

Another example are genes that code for signal transduction proteins - like Ras genes, that code for Ras proteins.

Ras proteins are GTP-ases, meaning that they bind an intracellular GTP molecule, and break it down into GDP and a free phosphate group.

This further activates various cellular pathways, which ultimately result in cell growth, differentiation, and survival.

Another example is the MYC proto-oncogene which codes for a transcription factor that increases expression of cyclins and cyclin dependent kinases.

On the other hand, there are also proto-oncogenes that code for proteins that inhibit apoptosis.

An example is bcl-2 which prevents the activation of caspases - the enzymes that actually carries out apoptosis.

Now, proto-oncogenes are normally only active when a cell needs to grow and divide - like you only push the accelerator pedal in a car when you want to speed up.

However, some genetic mutations like translocations, amplifications, or point mutations turn proto-oncogenes into oncogenes.

When a gene is an oncogene it gets overexpressed - meaning, it results in too many proteins, or it means that it codes for hyperactive proteins - which would be kinda like leaving a brick on the gas pedal and going to take a nap in the backseat as the car speeds down the highway.

Cells have two copies of proto-oncogenes; however, if there’s a dominant mutation, that means that just one mutant oncogene copy is enough for the cell to avoid apoptosis and keep growing and dividing uncontrollably.

One example is a type of B cell lymphoma called Burkitt lymphoma, which can result from a chromosomal translocation.

When that happens the Myc gene is translocated from chromosome 8 to a spot where it’s right next to the IgH promoter on chromosome 14 which upregulates - or stimulates - its expression.

Key Takeaways

Oncogenes and tumor suppressor genes are types of genes that play a role in the development of cancer. Oncogenes are mutated versions of proto-oncogenes, which normally regulate and promote the cell cycle to progress. Oncogenes end up promoting uncontrolled cell growth and division, causing normal cells to become cancerous. On the other hand, tumor suppressor genes are genes that code for protein products that regulate and slow down the cell cycle, and also promote apoptosis, which is programmed cell death.